BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23852449)

  • 21. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer.
    Abel EV; Kim EJ; Wu J; Hynes M; Bednar F; Proctor E; Wang L; Dziubinski ML; Simeone DM
    PLoS One; 2014; 9(3):e91983. PubMed ID: 24647545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway.
    Jin L; Vu T; Yuan G; Datta PK
    Cancer Res; 2017 Oct; 77(20):5464-5478. PubMed ID: 28827371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer.
    Yuan R; Ke J; Sun L; He Z; Zou Y; He X; Chen Y; Wu X; Cai Z; Wang L; Wang J; Fan X; Wu X; Lan P
    Clin Exp Metastasis; 2015 Feb; 32(2):169-79. PubMed ID: 25636905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells.
    Capodanno Y; Buishand FO; Pang LY; Kirpensteijn J; Mol JA; Argyle DJ
    Endocr Relat Cancer; 2018 Feb; 25(2):131-144. PubMed ID: 29175872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
    Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
    Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.
    Smith ML; Hawcroft G; Hull MA
    Eur J Cancer; 2000 Mar; 36(5):664-74. PubMed ID: 10738133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Met inhibition is required for the celecoxib-attenuated stemness property of human colorectal cancer cells.
    Lin YM; Lu CC; Hsiang YP; Pi SC; Chen CI; Cheng KC; Pan HL; Chien PH; Chen YJ
    J Cell Physiol; 2019 Jul; 234(7):10336-10344. PubMed ID: 30480806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
    Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
    J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.
    Hassan KA; Wang L; Korkaya H; Chen G; Maillard I; Beer DG; Kalemkerian GP; Wicha MS
    Clin Cancer Res; 2013 Apr; 19(8):1972-80. PubMed ID: 23444212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.
    Groeneweg JW; Hall TR; Zhang L; Kim M; Byron VF; Tambouret R; Sathayanrayanan S; Foster R; Rueda BR; Growdon WB
    Gynecol Oncol; 2014 Jun; 133(3):607-15. PubMed ID: 24667249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Notch pathway activation is associated with pancreatic cancer treatment failure.
    Lee JY; Song SY; Park JY
    Pancreatology; 2014; 14(1):48-53. PubMed ID: 24555978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
    Dihlmann S; Siermann A; von Knebel Doeberitz M
    Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
    Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
    Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of peroxisome proliferator-activated receptor gamma does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin on human colorectal cancer cells.
    Hawcroft G; Gardner SH; Hull MA
    J Pharmacol Exp Ther; 2003 May; 305(2):632-7. PubMed ID: 12606626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
    Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T
    Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy.
    Feng Y; Gao S; Gao Y; Wang X; Chen Z
    Oncotarget; 2016 Dec; 7(49):81402-81409. PubMed ID: 27833077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation.
    Takada Y; Bhardwaj A; Potdar P; Aggarwal BB
    Oncogene; 2004 Dec; 23(57):9247-58. PubMed ID: 15489888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indomethacin induces cellular morphological change and migration via epithelial-mesenchymal transition in A549 human lung cancer cells: a novel cyclooxygenase-inhibition-independent effect.
    Kato T; Fujino H; Oyama S; Kawashima T; Murayama T
    Biochem Pharmacol; 2011 Dec; 82(11):1781-91. PubMed ID: 21840302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation.
    Nayak A; Das S; Nayak D; Sethy C; Narayan S; Kundu CN
    Cell Oncol (Dordr); 2019 Apr; 42(2):157-171. PubMed ID: 30603978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.